The Successful Launch and Diffusion of New Therapies - Innovation and Marketing in the Pharmaceutical Industry - page 211

Table 7.3 Mean lead (−) or lag (+) in launch window and % deviation from mean price at launch
by world region and country a

Mean lead (−) or lag (+) in
launch window (in months)

% Deviation from mean
price at launch per gram World region and countries

North America −8.95 37.87

USA −17.17 37.79

Canada −7.50 −1.57

Puerto Rico −7.21 93.09

Mexico −3.94 22.16

Western Europe −5.81 −8.15

Germany −15.59 −9.17

Denmark −10.65 −5.35

U.K. −9.82 −0.14

Austria −9.13 −9.92

Switzerland −8.97 0.21

Ireland −8.08 −5.22

Sweden −7.11 −8.48

Netherlands −6.95 −6.93

Finland −6.44 −4.39

Norway −5.87 3.83

Spain −4.03 −17.22

Belgium −3.45 −13.61

Luxemburg −2.22 −12.78

Portugal −1.66 −11.47

Italy −1.01 −13.26

France −0.46 −12.44

Greece 2.06 −12.21

South America −0.43 7.93

Brazil −6.79 14.43

Argentina −6.36 0.89

Colombia −3.12 33.67

Chile −2.27 −8.19

Venezuela 1.97 17.49

Uruguay 3.95 12.72

Peru 4.29 −4.20

Ecuador 4.91 −3.39

Oceania 0.10 −8.02

Australia −1.55 −11.82

New Zealand 1.75 −4.21

Asia 5.16 11.01

Philippines −2.17 −12.15

Japan 6.89 47.89

Korea 10.75 −2.71

Eastern Europe 8.74 −1.62

Czech Republic 5.03 1.58

Estonia 5.21 −3.51

Hungary 5.68 −5.54

Poland 8.91 1.71

Latvia 9.55 −5.78